Home > Insider Trading > Merrimack Pharmaceuticals Inc

Merrimack Pharmaceuticals Inc (MACK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Hedge Fund and Insider Trading News: Crispin Odey, Dan Loeb, Carl Icahn, Bridgewater Associates, Timefolio Asset Management, CVB Financial Corp (CVBF), Cerevel Therapeutics Holdings, Inc. (CERE), and More

Freddie Neave, the hedge fund manager who replaced Crispin Odey to take charge of Odey Asset Management's European Inc.

Keep Reading →

August 10th, 2023 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Bill Ackman, Cathie Wood, Crispin Odey, Elliott Management, Millennium Management, Modulo Capital, Maniyar Capital Advisors, Pyxis Oncology, Inc. (PYXS), Merrimack Pharmaceuticals Inc (MACK), and More

The U.S.

Keep Reading →

March 23rd, 2023 - Hedge Funds Insider Trading

12 Best Performing Biotech Stocks in 2022

Fitch Ratings has assigned a Neutral rating to the global pharmaceutical and biotech industry, which indicates the assumption of a collaborative operating backdrop in 2023, although inflationary pressures...

Keep Reading →

December 28th, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: Kyle Bass, Daniel Och, Bill Ackman, Perceptive Advisors, Schonfeld Strategic Advisors, Coatue Management, Merrimack Pharmaceuticals Inc (MACK), AMC Entertainment Holdings Inc (AMC), and More

Closely watched hedge fund manager Kyle Bass said Thursday that oil prices could rise "well north of $100" in 2022 as a lack of investment in the hydrocarbon industry meets a surge in demand as the global...

Keep Reading →

January 14th, 2022 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Steve Cohen, Bill Ackman, Nicolai Tangen, Dan Loeb, Legion Partners Asset Management, Tyr Capital Partners, Archegos Capital Management, Artis Real Estate Investment Trust Unit (ARESF), Moderna Inc (MRNA), and More

BOSTON (Reuters) - Activist investor Legion Partners Asset Management LLC has nominated seven directors to sit on specialty retailer Genesco Inc’s eight-person board, according to a letter made public...

Keep Reading →

April 12th, 2021 - Hedge Funds Insider Trading

Where Do Hedge Funds Stand On Merrimack Pharmaceuticals Inc (MACK)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

November 29th, 2020 - Hedge Funds News

Hedge Fund and Insider Trading News: Ray Dalio, Warren Buffett, Fortress Investment Group, Fulcrum Asset Management, Guess?, Inc. (GES), Merrimack Pharmaceuticals Inc (MACK), and More

A ransomware attack against a vendor of SEI Investments Co.

Keep Reading →

July 27th, 2020 - Hedge Funds Insider Trading

Hedge Funds Are Selling Merrimack Pharmaceuticals Inc (MACK)

Is Merrimack Pharmaceuticals Inc (NASDAQ:MACK) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research...

Keep Reading →

December 22nd, 2019 - Hedge Funds News